An update on T2-toxins: metabolism, immunotoxicity mechanism and human assessment exposure of intestinal microbiota
- PMID: 35928103
- PMCID: PMC9344027
- DOI: 10.1016/j.heliyon.2022.e10012
An update on T2-toxins: metabolism, immunotoxicity mechanism and human assessment exposure of intestinal microbiota
Abstract
Mycotoxins are naturally produced secondary metabolites or low molecular organic compounds produced by fungus with high diversification, which cause mycotoxicosis (food contamination) in humans and animals. T-2 toxin is simply one of the metabolites belonging to fungi trichothecene mycotoxin. Specifically, Trichothecenes-2 (T-2) mycotoxin of genus fusarium is considered one of the most hotspot agricultural commodities and carcinogenic compounds worldwide. There are well-known examples of salmonellosis in mice and pigs, necrotic enteritis in chickens, catfish enteric septicemia and colibacillosis in pigs as T-2 toxic agent. On the other hand, it has shown a significant reduction in the Salmonella population's aptitude in the pig intestinal tract. Although the impact of the excess Fusarium contaminants on humans in creating infectious illness is less well-known, some toxins are harmful; for example, salmonellosis and colibacillosis have been frequently observed in humans. More than 20 different metabolites are synthesized and excreted after ingestion, but the T-2 toxin is one of the most protuberant metabolites. Less absorption of mycotoxins in intestinal tract results in biotransformation of toxic metabolites into less toxic variants. In addition to these, effects of microbiota on harmful mycotoxins are not limited to intestinal tract, it may harm the other human vital organs. However, detoxification of microbiota is considered as an alternative way to decontaminate the feed for both animals and humans. These transformations of toxic metabolites depend upon the formation of metabolites. This study is complete in all perspectives regarding interactions between microbiota and mycotoxins, their mechanism and practical applications based on experimental studies.
Keywords: Gastrointestinal tract; Gut microbiota; Human; T-2 toxins; Toxicological effects.
© 2022 Published by Elsevier Ltd.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Zain M.E. Impact of mycotoxins on humans and animals. J. Saudi Chem. Soc. 2011;15(2):129–144.
-
- Fink-Gremmels J., Georgiou N. NL-Wageningen Press; Wageningen: 1996. Risk Assessment of Mycotoxins for the Consumers. Residues of Veterinary Drugs and Mycotoxins in Animal Products; pp. 159–174.
-
- Sudakin D.L. Trichothecenes in the environment: relevance to human health. Toxicol. Lett. 2003;143(2):97–107. - PubMed
-
- Afsah-Hejri L., et al. A review on mycotoxins in food and feed: Malaysia case study. Compr. Rev. Food Sci. Food Saf. 2013;12(6):629–651. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
